Stocks · News reference
Here’s How Much You Would Have Made Owning Corcept Therapeutics Stock In The Last 10 Years
Corcept Therapeutics (NASDAQ:CORT) has outperformed the market over the past 10 years by 20.4% on an annualized basis producing an average annual return of 33.86%. Currently, Corcept Therapeutics has a market
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Stock Market Today: Microsoft Ignites Chip Rebound as SanDisk Jumps 24%
Microsoft's 43% cloud growth revived the AI trade and lifted chipmakers, but Meta's guidance miss and a 19-year high in 30-year yields capped the rebound.
Canaccord Genuity Maintains Buy on Corcept Therapeutics, Raises Price Target to $161
Lam Research, Xerox, FormFactor, Microsoft And Other Big Stocks Moving Higher On Thursday
Dow Jones index gained 300 points, Lam Research Corp rose 20.1% after reporting strong financial results. Xerox, Columbus McKinnon, and other stocks recorded gains.